reference/33724083

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33724083

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	e24
issn	1558-7673
issueIdentifier	1
pageRange	e19-e24
publicationName	Clinical Genitourinary Cancer
startingPage	e19
bibliographicCitation	Miyake H, Imai S, Harada K, Fujisawa M. Absence of Significant Correlation of Adverse Events Between First- and Second-Line Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2016 Feb;14(1):e19–24. doi: 10.1016/j.clgc.2015.08.002. PMID: 26382221.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64ac991e476c6101f383ef719e9a8086 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87a03b162b11b996a593a3af8264ee41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_515d9afa13df8af0a98280250e119d10 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_750e27ff50a198843644793502b2e583
date	201602
identifier	https://doi.org/10.1016/j.clgc.2015.08.002 https://pubmed.ncbi.nlm.nih.gov/26382221
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32764 https://portal.issn.org/resource/ISSN/1558-7673
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Absence of Significant Correlation of Adverse Events Between First- and Second-Line Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma
discusses	http://id.nlm.nih.gov/mesh/M0011238 http://id.nlm.nih.gov/mesh/M0018276 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0446095 http://id.nlm.nih.gov/mesh/M0489638 http://id.nlm.nih.gov/mesh/M0448793 http://id.nlm.nih.gov/mesh/M0011048 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0016578 http://id.nlm.nih.gov/mesh/M0011208 http://id.nlm.nih.gov/mesh/M0014833
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002292Q000188 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D047428Q000009 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D007680Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007093Q000009 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011758Q000627 http://id.nlm.nih.gov/mesh/D000077157 http://id.nlm.nih.gov/mesh/D007211Q000627 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D007211Q000009 http://id.nlm.nih.gov/mesh/D010671Q000009 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D007191Q000009 http://id.nlm.nih.gov/mesh/D010671Q000627 http://id.nlm.nih.gov/mesh/D000077210 http://id.nlm.nih.gov/mesh/D007680Q000473 http://id.nlm.nih.gov/mesh/D007093Q000627 http://id.nlm.nih.gov/mesh/D008175Q000556 http://id.nlm.nih.gov/mesh/D002292Q000556 http://id.nlm.nih.gov/mesh/D002292Q000401 http://id.nlm.nih.gov/mesh/D008175Q000401 http://id.nlm.nih.gov/mesh/D009536Q000627 http://id.nlm.nih.gov/mesh/D009536Q000031 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D000077784 http://id.nlm.nih.gov/mesh/D007680Q000401 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D007191Q000627 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D011758Q000009 http://id.nlm.nih.gov/mesh/D009536Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11386 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8140 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453

Total number of triples: 77.